PDB Short entry for 2UZU HEADER TRANSFERASE 01-MAY-07 2UZU TITLE PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT TITLE 2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC COMPND 3 SUBUNIT; COMPND 4 CHAIN: E; COMPND 5 FRAGMENT: RESIDUES 15-350; COMPND 6 SYNONYM: PKA C-ALPHA, PROTEIN KINASE A; COMPND 7 EC: 2.7.11.11; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 11 CHAIN: I; COMPND 12 FRAGMENT: RESIDUES 5-24; COMPND 13 SYNONYM: PKI-ALPHA; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 9 ORGANISM_COMMON: BOVINE; SOURCE 10 ORGANISM_TAXID: 9913; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CAMP, KINASE, MYRISTATE, TRANSFERASE, LIPOPROTEIN, KEYWDS 2 SERINE/THREONINE-PROTEIN KINASE, PHOSPHORYLATION, PROTEIN KEYWDS 3 KINASE A, NUCLEOTIDE-BINDING, PROTEIN KINASE INHIBITOR, KEYWDS 4 ATP- BINDING, AKT INHIBITORS, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.D.ZHU,V.B.GANDHI,J.GONG,S.THOMAS,K.W.WOODS,X.SONG,T.LI, AUTHOR 2 R.B.DIEBOLD,Y.LUO,X.LIU,R.GUAN,V.KLINGHOFER,E.F.JOHNSON, AUTHOR 3 J.BOUSKA,A.OLSON,K.C.MARSH,V.S.STOLL,M.MAMO,J.POLAKOWSKI, AUTHOR 4 T.J.CAMPBELL,T.D.PENNING,Q.LI,S.H.ROSENBERG,V.L.GIRANDA REVDAT 3 24-FEB-09 2UZU 1 VERSN REVDAT 2 03-JUL-07 2UZU 1 JRNL REVDAT 1 05-JUN-07 2UZU 0 JRNL AUTH G.D.ZHU,V.B.GANDHI,J.GONG,S.THOMAS,K.W.WOODS, JRNL AUTH 2 X.SONG,T.LI,R.B.DIEBOLD,Y.LUO,X.LIU,R.GUAN, JRNL AUTH 3 V.KLINGHOFER,E.F.JOHNSON,J.BOUSKA,A.OLSON, JRNL AUTH 4 K.C.MARSH,V.S.STOLL,M.MAMO,J.POLAKOWSKI, JRNL AUTH 5 T.J.CAMPBELL,R.L.MARTIN,G.A.GINTANT,T.D.PENNING, JRNL AUTH 6 Q.LI,S.H.ROSENBERG,V.L.GIRANDA JRNL TITL SYNTHESES OF POTENT, SELECTIVE, AND ORALLY JRNL TITL 2 BIOAVAILABLE INDAZOLE-PYRIDINE SERIES OF PROTEIN JRNL TITL 3 KINASE B/AKT INHIBITORS WITH REDUCED HYPOTENSION. JRNL REF J.MED.CHEM. V. 50 2990 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17523610 JRNL DOI 10.1021/JM0701019 REMARK 2 REMARK 2 RESOLUTION. 2.4 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.4 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.0 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 16204 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.3183 REMARK 3 FREE R VALUE : 0.3707 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.1 REMARK 3 FREE R VALUE TEST SET COUNT : 1605 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.8 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2079 REMARK 3 BIN R VALUE (WORKING SET) : 0.329 REMARK 3 BIN FREE R VALUE : 0.385 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.8 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 226 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2927 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.9 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.293 REMARK 3 B22 (A**2) : 0.695 REMARK 3 B33 (A**2) : 4.598 REMARK 3 B12 (A**2) : 0.000 REMARK 3 B13 (A**2) : 0.000 REMARK 3 B23 (A**2) : 0.000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.3 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.1 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.75 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.423073 REMARK 3 BSOL : 47.1505 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : LIG.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2UZU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAY-07. REMARK 100 THE PDBE ID CODE IS EBI-32452. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17714 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA):NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.37750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.02450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.37400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.02450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.37750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.37400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO E 124 CG CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA E 38 -177.77 -170.18 REMARK 500 LYS E 47 140.61 -172.97 REMARK 500 SER E 53 -61.34 -16.03 REMARK 500 ASP E 112 -158.42 -135.87 REMARK 500 ASP E 166 41.85 -144.57 REMARK 500 LYS E 168 145.99 168.70 REMARK 500 ASP E 184 100.04 61.54 REMARK 500 ASN E 216 -158.81 -139.02 REMARK 500 LEU E 273 49.88 -91.11 REMARK 500 LEU E 277 7.95 -62.15 REMARK 500 LYS E 279 15.92 -153.32 REMARK 500 VAL E 288 -58.45 -29.07 REMARK 500 ALA E 298 -28.36 -39.48 REMARK 500 SER E 325 3.26 -68.13 REMARK 500 HIS I 23 -34.49 -174.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L20 E1351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KMU RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REMARK 900 REGULATORY SUBUNITDIMERIC COMPLEX OF THE CAMP REMARK 900 -DEPENDENT PROTEIN KINASE REMARK 900 RELATED ID: 1KMW RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REMARK 900 REGULATORY SUBUNITDIMERIC COMPLEX OF THE C- REMARK 900 AMP-DEPENDENT PROTEIN KINASE REMARK 900 RELATED ID: 1Q24 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX REMARK 900 WITH MGATP REMARK 900 RELATED ID: 1Q61 RELATED DB: PDB REMARK 900 PKA TRIPLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 1Q62 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 1Q8T RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 900 PROTEIN KINASE(PKA) IN COMPLEX WITH RHO- REMARK 900 KINASE INHIBITOR Y-27632 REMARK 900 RELATED ID: 1Q8U RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 900 PROTEIN KINASE INCOMPLEX WITH RHO-KINASE REMARK 900 INHIBITOR H-1152P REMARK 900 RELATED ID: 1Q8W RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 900 PROTEIN KINASE INCOMPLEX WITH RHO-KINASE REMARK 900 INHIBITOR FASUDIL (HA-1077) REMARK 900 RELATED ID: 1SMH RELATED DB: PDB REMARK 900 PROTEIN KINASE A VARIANT COMPLEX WITH REMARK 900 COMPLETELY ORDERED N-TERMINAL HELIX REMARK 900 RELATED ID: 1STC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC REMARK 900 SUBUNIT INCOMPLEX WITH STAUROSPORINE REMARK 900 RELATED ID: 1SVE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN REMARK 900 COMPLEX WITHAZEPANE DERIVATIVE 1 REMARK 900 RELATED ID: 1SVG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN REMARK 900 COMPLEX WITHAZEPANE DERIVATIVE 4 REMARK 900 RELATED ID: 1SVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN REMARK 900 COMPLEX WITHAZEPANE DERIVATIVE 8 REMARK 900 RELATED ID: 1SZM RELATED DB: PDB REMARK 900 DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 REMARK 900 TO PROTEINKINASE A (PKA) REMARK 900 RELATED ID: 1VEB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN REMARK 900 COMPLEX WITHAZEPANE DERIVATIVE 5 REMARK 900 RELATED ID: 1XH4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B REMARK 900 SELECTIVE INHIBITORSIN COMPLEX WITH PROTEIN REMARK 900 KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B REMARK 900 SELECTIVE INHIBITORSIN COMPLEX WITH PROTEIN REMARK 900 KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B REMARK 900 SELECTIVE INHIBITORSIN COMPLEX WITH PROTEIN REMARK 900 KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B REMARK 900 SELECTIVE INHIBITORSIN COMPLEX WITH PROTEIN REMARK 900 KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B REMARK 900 SELECTIVE INHIBITORSIN COMPLEX WITH PROTEIN REMARK 900 KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B REMARK 900 SELECTIVE INHIBITORSIN COMPLEX WITH PROTEIN REMARK 900 KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XHA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B REMARK 900 SELECTIVE INHIBITORSIN COMPLEX WITH PROTEIN REMARK 900 KINASE A AND MUTANTS REMARK 900 RELATED ID: 1YDR RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, REMARK 900 ALPHA-CATALYTICSUBUNIT IN COMPLEX WITH H7 REMARK 900 PROTEIN KINASE INHIBITOR1-(5- REMARK 900 ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE REMARK 900 RELATED ID: 1YDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, REMARK 900 ALPHA-CATALYTICSUBUNIT IN COMPLEX WITH H8 REMARK 900 PROTEIN KINASE INHIBITOR[N-(2-METHYLAMINO) REMARK 900 ETHYL]-5-ISOQUINOLINESULFONAMIDE REMARK 900 RELATED ID: 1YDT RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, REMARK 900 ALPHA-CATALYTICSUBUNIT IN COMPLEX WITH H89 REMARK 900 PROTEIN KINASE INHIBITORN-[2-(4- REMARK 900 BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE REMARK 900 RELATED ID: 2C1A RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE REMARK 900 COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID ( REMARK 900 2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL) REMARK 900 AMIDE REMARK 900 RELATED ID: 2C1B RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE REMARK 900 COMPLEXED WITH (4R,2S)-5'-(4-(4- REMARK 900 CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL) REMARK 900 ISOQUINOLINE REMARK 900 RELATED ID: 2F7E RELATED DB: PDB REMARK 900 PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL REMARK 900 )-1-(5-ISOQUINOLIN-6-YL-PYRIDIN-3- REMARK 900 YLOXYMETHYL-ETYLAMINE REMARK 900 RELATED ID: 2GFC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC REMARK 900 SUBUNIT WITHPKI-5-24 REMARK 900 RELATED ID: 2GNF RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF REMARK 900 RHO-KINASE WITH Y-27632 REMARK 900 RELATED ID: 2GNG RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF REMARK 900 RHO-KINASE REMARK 900 RELATED ID: 2GNH RELATED DB: PDB REMARK 900 PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE REMARK 900 WITH H1152P REMARK 900 RELATED ID: 2GNI RELATED DB: PDB REMARK 900 PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE REMARK 900 WITH INHIBITORFASUDIL (HA1077) REMARK 900 RELATED ID: 2GNJ RELATED DB: PDB REMARK 900 PKA THREE FOLD MUTANT MODEL OF RHO-KINASE REMARK 900 WITH Y-27632 REMARK 900 RELATED ID: 2GNL RELATED DB: PDB REMARK 900 PKA THREEFOLD MUTANT MODEL OF RHO-KINASE REMARK 900 WITH INHIBITOR H-1152P REMARK 900 RELATED ID: 2JDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE REMARK 900 COMPLEXED WITH A-443654 REMARK 900 RELATED ID: 2JDT RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4- REMARK 900 CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE REMARK 900 RELATED ID: 2JDV RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 A-443654 REMARK 900 RELATED ID: 2UVX RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 7-AZAINDOLE REMARK 900 RELATED ID: 2UVY RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 METHYL-(4-(9H-PURIN-6-YL)-BENZYL)-AMINE REMARK 900 RELATED ID: 2UVZ RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 C-PHENYL-C-(4-(9H-PURIN-6-YL)-PHENYL REMARK 900 )-METHYLAMINE REMARK 900 RELATED ID: 2UW0 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 6-(4-(4-(4-CHLORO-PHENYL)-PIPERIDIN-4- REMARK 900 YL)-PHENYL)-9H-PURINE REMARK 900 RELATED ID: 2UW3 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 5-METHYL-4-PHENYL-1H-PYRAZOLE REMARK 900 RELATED ID: 2UW4 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 2-(4-(5-METHYL-1H-PYRAZOL-4-YL)-PHENYL REMARK 900 )-ETHYLAMINE REMARK 900 RELATED ID: 2UW5 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 (R)-2-(4-CHLORO-PHENYL)-2-(4-1H- REMARK 900 PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE REMARK 900 RELATED ID: 2UW6 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 (S)-2-(4-CHLORO-PHENYL)-2-(4-1H- REMARK 900 PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE REMARK 900 RELATED ID: 2UW7 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4 REMARK 900 -YL)-PHENYL)-PIPERIDINE REMARK 900 RELATED ID: 2UW8 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH REMARK 900 2-(4-CHLORO-PHENYL)-2-PHENYL-ETHYLAMINE REMARK 900 RELATED ID: 2UZT RELATED DB: PDB REMARK 900 PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2UZW RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES REMARK 900 OF AKT INHIBITORS REMARK 900 RELATED ID: 2UZV RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES REMARK 900 OF AKT INHIBITORS DBREF 2UZU E 15 350 UNP P00517 KAPCA_BOVIN 15 350 DBREF 2UZU I 5 24 UNP Q3SX13 IPKA_BOVIN 5 24 SEQADV 2UZU ASP E 286 UNP P00517 ASN 286 CONFLICT SEQRES 1 E 336 VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE LEU SEQRES 2 E 336 LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA HIS LEU SEQRES 3 E 336 ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR GLY SER SEQRES 4 E 336 PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU THR GLY SEQRES 5 E 336 ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS VAL SEQRES 6 E 336 VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU LYS SEQRES 7 E 336 ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL LYS SEQRES 8 E 336 LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR MET SEQRES 9 E 336 VAL MET GLU TYR VAL PRO GLY GLY GLU MET PHE SER HIS SEQRES 10 E 336 LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA ARG SEQRES 11 E 336 PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR LEU SEQRES 12 E 336 HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO GLU SEQRES 13 E 336 ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL THR SEQRES 14 E 336 ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR TRP SEQRES 15 E 336 THR LEU CYS GLY THR PRO GLU TYR LEU ALA PRO GLU ILE SEQRES 16 E 336 ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP TRP SEQRES 17 E 336 ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY TYR SEQRES 18 E 336 PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR GLU SEQRES 19 E 336 LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS PHE SEQRES 20 E 336 SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU GLN SEQRES 21 E 336 VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASP GLY SEQRES 22 E 336 VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR THR SEQRES 23 E 336 ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA PRO SEQRES 24 E 336 PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER ASN SEQRES 25 E 336 PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SER ILE SEQRES 26 E 336 ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP HET L20 E1351 30 HETNAM L20 (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H- HETNAM 2 L20 INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE FORMUL 3 L20 C24 H23 N5 O HELIX 1 1 VAL E 15 GLU E 31 1 17 HELIX 2 2 HIS E 39 ASP E 41 5 3 HELIX 3 3 LYS E 76 LEU E 82 1 7 HELIX 4 4 GLN E 84 GLN E 96 1 13 HELIX 5 5 GLU E 127 GLY E 136 1 10 HELIX 6 6 SER E 139 LEU E 160 1 22 HELIX 7 7 LYS E 168 GLU E 170 5 3 HELIX 8 8 THR E 201 LEU E 205 5 5 HELIX 9 9 ALA E 206 LEU E 211 1 6 HELIX 10 10 LYS E 217 GLY E 234 1 18 HELIX 11 11 GLN E 242 GLY E 253 1 12 HELIX 12 12 SER E 262 LEU E 273 1 12 HELIX 13 13 GLY E 287 ASN E 293 1 7 HELIX 14 14 HIS E 294 ALA E 298 5 5 HELIX 15 15 ASP E 301 GLN E 307 1 7 HELIX 16 16 THR I 5 SER I 13 1 9 SHEET 1 EA 5 PHE E 43 GLY E 52 0 SHEET 2 EA 5 GLY E 55 HIS E 62 -1 O GLY E 55 N GLY E 52 SHEET 3 EA 5 ASN E 67 ASP E 75 -1 O ASN E 67 N HIS E 62 SHEET 4 EA 5 ASN E 115 GLU E 121 -1 O LEU E 116 N LEU E 74 SHEET 5 EA 5 LEU E 106 LYS E 111 -1 O PHE E 108 N VAL E 119 SHEET 1 EB 2 LEU E 162 ILE E 163 0 SHEET 2 EB 2 LYS E 189 ARG E 190 -1 O LYS E 189 N ILE E 163 SHEET 1 EC 2 LEU E 172 ILE E 174 0 SHEET 2 EC 2 ILE E 180 VAL E 182 -1 O GLN E 181 N LEU E 173 SITE 1 AC1 14 THR E 51 PHE E 54 GLY E 55 ARG E 56 SITE 2 AC1 14 ALA E 70 LYS E 72 LEU E 74 GLU E 121 SITE 3 AC1 14 TYR E 122 VAL E 123 LEU E 173 THR E 183 SITE 4 AC1 14 ASP E 184 PHE E 327 CRYST1 72.755 74.748 80.049 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013745 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013378 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012492 0.00000